Complex diseases rarely follow a single pathway. Yet modern drug discovery is still largely built around single targets, isolated datasets, and fragmented development systems. Canurta is exploring botanicals for their potential to act across multiple biological pathways, opening new possibilities for how we develop medicines. We bring therapeutic development, consumer health product innovation, and predictive intelligence into one platform. Together, they connect complex natural molecules with human outcomes, turning evidence from products in market into insights for the next generation of botanical medicines.
| Website | http://www.canurta.com |
| Employees | 17 (7 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | New Medicines, Biotechnology, Pharmaceutical Research, Chronic Disease Reversal, Bioprocessing, Drug Discovery, Plant Based Medicine, Natural Therapeutics, Botanical Extracts, Advanced Technologies, Therapeutics Research, Disease Treatment, Biotech Research, Plant Derived Compounds, Health Solutions |
| Competitors | Leafly, Weedmaps, Eaze, CannaCraft, helloMD, MedMen, Flow Kana, Curaleaf, Cresco Labs, Trulieve +34 more (view full list) |
Looking for a particular Canurta employee's phone or email?
Pamela Kisun is the COO of Canurta.
7 people are employed at Canurta.
Canurta is based in Mississauga, Ontario.